JamesFSimonMD

Nephrology • Cleveland, OH

Fellowship Program Director at Cleveland Clinic

Join to view full profile

Dr. Simon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Simon's full profile

Already have an account?

Office
9500 Euclid Ave # Q7

Cleveland, OH 44195
Phone+1 216-445-4891
Is this information wrong?

Education & Training

National Capital Consortium (Walter Reed)Fellowship, Nephrology, 2002 - 2004
San Antonio Uniformed Services Health Education ConsortiumResidency, Internal Medicine, 1998 - 2001
Loyola University Chicago Stritch School of MedicineClass of 1998

Certifications & Licensure

OH State Medical License 2007 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Clinical Trials

Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients Start of enrollment: 2010 Jul 01
Terminated
Phase 3
MEmbranous Nephropathy Trial Of Rituximab Start of enrollment: 2011 Nov 01
Completed
Phase 2, Phase 3
ATHENA: Natural History of Disease Study in Alport Syndrome Patients Start of enrollment: 2014 Sep 04
Completed
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL Start of enrollment: 2017 Mar 02
Completed
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

283 citations
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Fernando C. Fervenza, Gerald B. Appel, Sean J. Barbour, Brad H. Rovin, Richard A. Lafayette
The New England Journal of Medicine. 2019-07-03
41 citations
Predictive Accuracy of a Perioperative Laboratory Test-Based Prediction Model for Moderate to Severe Acute Kidney Injury After Cardiac Surgery.
Sevag Demirjian, C Allen Bashour, Andrew Shaw, Jesse D Schold, James Simon
JAMA. 2022-03-08
39 citations
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
Fernando C. Fervenza, Pietro A. Canetta, Sean J. Barbour, Richard A. Lafayette, Brad H. Rovin
Nephron. 2015-01-01

Press Mentions

Ohio’s Rising Coronavirus Cases Suggest a Fall Surge Is Coming -- Are Northeast Ohio Hospitals Ready?October 26th, 2020
Kidney Patients with Alport Syndrome Are Center of FDA Patient-Focused MeetingAugust 3rd, 2018
What to Do if You Think Your Child Has Flu (Infographic)October 27th, 2016
Join now to see all

Hospital Affiliations

Cleveland ClinicCleveland, Ohio